Background Comorbidity is highly prevalent between substance use disorders (SUDs) and
schizophrenia. This systematic review and meta-analysis estimated prevalence rates of …

Background Although the link between cannabis use and development of psychosis is well
established, less is known about the effect of continued versus discontinued cannabis use …

Objectives The liberalisation of cannabis laws, the increasing availability and potency of
cannabis has renewed concern about the risk of psychosis with cannabis. Methods The …

Objectives: Cannabis use is prevalent among people with first episode psychosis and the
epidemiology of its use in early psychosis is unclear. We performed a meta-analysis of …

Objective: The use of cannabis during the early stage of psychosis has been linked with
increased psychotic symptoms. This study aimed to examine the use of cannabis in the 12 …

With the proposed Canadian July 2018 legalization of marijuana through the Cannabis Act,
a thorough critical analysis of the current trials on the efficacy of medicinal marijuana (MM) …

Objective: No evidence-based intervention effectively reduces cannabis use in young adults
with psychosis (YAP). To generate hypotheses about why, a scoping review was conducted …

A convergence of evidence shows that use of Cannabis sativa is associated with increased
risk of developing psychotic disorders, including schizophrenia, and earlier age at which …

Substance use is common in first-episode psychosis (FEP) and has been linked to poorer
outcomes with more severe psychopathology and higher relapse rates. Early substance …

Lifetime co-occurring substance use disorders are common at the time of presentation for
treatment of a first episode of primary psychosis and persistent substance use disorder …